USTCX Performance — Victory Science & Technology Fund, Class A
Data updated: 2026-09-29
USTCX returned +14.63% year to date and +24.45% over one year to Jul 2026. Annualised returns are +22.38% over 3 years and +5.15% over 5 years. The fund trailed its Technology Equity category average: $100 invested three years ago grew to $183, against $198 for the category, and to $124 over one year, against $131. Volatility over the past three years was 23.01% a year. In the 12 months to Jul 2026 the fund lost a net $18.4M, and assets reached $1.49B.
USTCX Growth of $100
What $100 invested in Victory Science & Technology Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Technology Equity category average over the same months.
| Period | USTCX | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $124 | $131 |
| 3 years (Aug 2023 – Jul 2026) | $183 | $198 |
| 5 years (Aug 2021 – Jul 2026) | $129 | $184 |
| Since data start (May 2020 – Jul 2026) | $214 | $315 |
USTCX Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +14.63% |
| 1 year | +24.45% |
| 3 years (annualised) | +22.38% |
| 5 years (annualised) | +5.15% |
USTCX Annual Returns
Calendar-year total returns of Victory Science & Technology Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +14.63% |
| 2025 | +17.84% |
| 2024 | +30.18% |
| 2023 | +33.62% |
| 2022 | −41.91% |
| 2021 | −3.25% |
| 2020 (May–Dec) | +61.75% |
USTCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | −1.7% | −4.4% | −4.7% | +18.2% | +13.9% | +1.8% | −6.6% | — | — | — | — | — |
| 2025 | +3.7% | −6.2% | −11.7% | +3.2% | +9.4% | +8.6% | +3.1% | +1.2% | +5.6% | +4.5% | −2.3% | −0.6% |
| 2024 | +1.7% | +8.2% | +1.5% | −6.3% | +4.8% | +5.9% | −1.2% | +3.4% | +2.4% | +0.2% | +9.0% | −1.9% |
| 2023 | +9.6% | −1.9% | +4.4% | −2.4% | +7.0% | +5.8% | +3.4% | −3.1% | −6.8% | −6.7% | +12.4% | +10.0% |
| 2022 | −14.7% | −4.8% | +0.1% | −16.2% | −4.8% | −6.9% | +10.4% | −3.7% | −10.0% | +2.2% | +5.1% | −6.3% |
| 2021 | −0.3% | +4.8% | −5.5% | +3.3% | −3.9% | +6.9% | −2.1% | +1.9% | −6.7% | +4.4% | −4.1% | −1.1% |
| 2020 | — | — | — | — | +11.6% | +6.7% | +4.8% | +5.7% | −3.3% | +1.5% | +15.1% | +8.7% |
USTCX Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 23.01%
- 3-year Sharpe ratio: 0.78 (vs 4.5% risk-free rate)
- Best month: +18.19% (Apr 2026)
- Worst month: −11.66% (Mar 2025)
USTCX Fund Flows
Monthly money in and out of Victory Science & Technology Fund, from SEC Form N-PORT.
- 12-month net flow: −$18.4M
- 12-month gross sales (incl. reinvestments): $186.0M
- Sales ÷ redemptions: 0.91×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $6.5M | $18.5M | −$12.0M |
| Jun 2026 | $8.2M | $17.8M | −$9.6M |
| May 2026 | $6.6M | $18.5M | −$11.8M |
| Apr 2026 | $7.5M | $21.9M | −$14.5M |
| Mar 2026 | $5.0M | $12.5M | −$7.5M |
| Feb 2026 | $6.2M | $16.7M | −$10.5M |
| Jan 2026 | $4.5M | $19.0M | −$14.5M |
| Dec 2025 | $123.6M | $19.4M | $104.2M |
| Nov 2025 | $4.6M | $15.3M | −$10.6M |
| Oct 2025 | $5.0M | $15.6M | −$10.6M |
| Sep 2025 | $5.5M | $16.7M | −$11.2M |
| Aug 2025 | $2.9M | $12.6M | −$9.8M |
USTCX Assets Under Management
Net assets of Victory Science & Technology Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $1.49B |
| 2026-04-30 | $1.41B |
| 2026-01-31 | $1.34B |
| 2025-10-31 | $1.45B |
| 2025-07-31 | $1.32B |
| 2025-04-30 | $1.10B |
| 2025-01-31 | $1.33B |
| 2024-10-31 | $1.22B |
| 2024-07-31 | $1.18B |
| 2024-04-30 | $1.12B |
| 2024-01-31 | $1.12B |
| 2023-10-31 | $921.45M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.